Significant:
Behavioural changes (e.g. agitation, anxiety, depression, dream abnormalities, obsessive-compulsive disorder). Rarely, systemic eosinophilia, vasculitis with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Ear and labyrinth disorders:
Otalgia, otitis media.
Eye disorders:
Myopia, conjunctivitis.
Gastrointestinal disorders:
Diarrhoea, nausea, vomiting, abdominal pain, dyspepsia, gastroenteritis.
General disorders and administration site conditions:
Pyrexia.
Infections and infestations:
Viral infection, tooth infection.
Investigations:
Elevated serum transaminase levels (ALT, AST).
Nervous system disorders:
Headache, drowsiness, dizziness.
Respiratory, thoracic and mediastinal disorders:
Upper respiratory tract infection, cough, acute bronchitis, influenza, laryngitis, pharyngitis, rhinorrhoea, sinusitis, sinus headache, pneumonia.
Skin and subcutaneous tissue disorders:
Rash, eczema or atopic dermatitis, skin infection, urticaria.
Vascular disorders:
Epistaxis.